Disclaimer: All products are for laboratory research only and not for human or animal use or consumption. For in-vitro research by qualified professionals only
$30.00
31 in stock (can be backordered)
Ships today if ordered and paid by 12 PM EST. (Except Saturdays & Sundays)
Due to our rigorous quality control standards and the fragile nature of our products, we cannot accept returns. In the rare occasion that your order arrives with missing, incorrect or damaged items, please email [email protected] for assistance. Our customer support representatives are standing by to ensure that our customers are 100% satisfied with our product quality, customer support and delivery. Cancellations must be requested by email before the order shipment has shipped. Once the order has shipped you may not cancel your order. Please contact us at [email protected] with any questions or concerns that you may have regarding your order. We will do our absolute best to assist you as quickly and satisfactorily as possible.Thank you.
GLP-1 Receptor Agonist Analog (SMA designation) is available as lyophilized powder in 5mg vials for preclinical metabolic research. This synthetic GLP-1 receptor agonist is designed for comprehensive investigation of incretin-mediated glucose regulation and insulin secretion pathways in laboratory models.
Chemical Composition:
• Chemical Name: GLP-1 Receptor Agonist Analog
• Molecular Formula: C195H305N51O60S7 (representative structure)
• Molecular Weight: ~4,113 g/mol (approximate)
• Compound Class: GLP-1 receptor agonist; incretin hormone analog
This GLP-1 receptor agonist analog represents a research-grade formulation engineered to activate GLP-1 receptor signaling with extended metabolic stability. The 5mg dosage supports initial dose-response characterization and baseline receptor engagement studies.
Research Applications:
• Glucose-stimulated insulin secretion (GSIS) enhancement in isolated islets
• GLP-1 receptor binding affinity and EC50 determination in transfected cells
• Beta cell proliferation assessment via BrdU incorporation assays
• Glucagon suppression efficiency evaluation in alpha cell preparations
• Blood glucose control profiling in diet-induced obesity animal models
Storage and Handling:
• Store lyophilized powder at -20°C in sealed, light-protected vials
• Maintain in desiccated conditions; prevent moisture exposure
• Reconstitute with sterile, endotoxin-free water for injection
• Solution stability: 7 days at 4°C once reconstituted
Product Specifications:
• Form: Lyophilized powder
• Quantity: 5mg per vial
• Purity: >95% by HPLC
• Appearance: White lyophilized cake
FOR RESEARCH USE ONLY. Not intended for human consumption or clinical use. All products are sold strictly for laboratory, educational, and scientific research purposes.